Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avatrombopag”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03471078
What this trial is testing

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Sobi, Inc. 122
Testing effectiveness (Phase 2)UnknownNCT06004752
What this trial is testing

Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly

Who this might be right for
Aplastic Anemia
Peking Union Medical College Hospital 30
Large-scale testing (Phase 3)Study completedNCT05369208
What this trial is testing

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 19
Very early researchWithdrawnNCT04931849
What this trial is testing

Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)

Who this might be right for
Thrombocytopenia
University of Rochester
Early research (Phase 1)Study completedNCT02039076
What this trial is testing

A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects

Who this might be right for
Thrombocytopenia
Eisai Inc. 48
Testing effectiveness (Phase 2)UnknownNCT04896528
What this trial is testing

Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

Who this might be right for
ThrombocytopeniaAvatrombopag
Peking Union Medical College Hospital 30
Not applicableUnknownNCT05087459
What this trial is testing

Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma

Who this might be right for
Thrombocytopenia
Shanghai Zhongshan Hospital 141
Large-scale testing (Phase 3)Ended earlyNCT03326843
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure

Who this might be right for
Thrombocytopenia
Sobi, Inc. 4
Testing effectiveness (Phase 2)WithdrawnNCT04312789
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

Who this might be right for
Platelet Disorder
Ayman Saad
Not applicableLooking for participantsNCT05823376
What this trial is testing

Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease

Who this might be right for
Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07786922
What this trial is testing

Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard Treatment

Who this might be right for
Aplastic Anemia
Swedish Orphan Biovitrum 26
Testing effectiveness (Phase 2)Study completedNCT02227693
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia

Who this might be right for
Thrombocytopenia Associated With Chronic Liver Disease
Eisai Co., Ltd. 39
Post-approval studies (Phase 4)Looking for participantsNCT07133659
What this trial is testing

Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

Who this might be right for
ITP - Immune Thrombocytopenia
Al-Mustansiriyah University 25
Not applicableEnded earlyNCT03554759
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure

Who this might be right for
Thrombocytopenia
Sobi, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT05772546
What this trial is testing

Avatrombopag vs. Placebo for CIT in GI Malignancies

Who this might be right for
Gastrointestinal CancerGastrointestinal NeoplasmsChemotherapy-Induced Thrombocytopenia
Hanny Al-Samkari, MD 49
Post-approval studies (Phase 4)UnknownNCT05382013
What this trial is testing

Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment

Who this might be right for
ThrombocytopeniaHepatitis B, ChronicAcute-On-Chronic Liver Failure
Third Affiliated Hospital, Sun Yat-Sen University 60
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Large-scale testing (Phase 3)Not Yet RecruitingNCT07278908
What this trial is testing

Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 248
Testing effectiveness (Phase 2)UnknownNCT05143892
What this trial is testing

Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Who this might be right for
Platelet Disorder
The First Affiliated Hospital of Soochow University 20
Not applicableUnknownNCT05518331
What this trial is testing

The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AA

Who this might be right for
Refractory Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 39
Next Page